Ingredient or product comparison
What evidence supports cyclical versus continuous GHK-Cu use?
Injectable GHK-Cu follows self-limiting courses of 6–8 weeks, with results assessed at the end of each course before any repeat. Topical GHK-Cu (the alternative route) runs continuously without cycling — it’s a low-dose, locally acting application with no syst
This source-based comparison does not add ratings or recommend a winner.
- Injectable GHK-Cu follows self-limiting courses of 6–8 weeks, with results assessed at the end of each course before any repeat. Topical GHK-Cu (the alternative route) runs continuously without cycling — it’s a low-dose, locally acting application with no systemic tolerance concerns. There is no evidence that continuous topical use loses effectiveness over time, though some users alternate between GHK-Cu and retinoid-based products to address different repair pathways.